December 28, 2015 / 3:22 PM / 2 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Chimerix, Freeport-McMoRan, pSivida

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) Wall Street began the last trading week of the year in the red, dragged down by energy stocks, as oil prices resumed a slide brought on by a global oversupply. The Dow Jones industrial average was down 0.51 percent at 17,462.32, the S&P 500 was down 0.64 percent at 2,047.79 and the Nasdaq Composite was down 0.67 percent at 5,014.714.

** CHIMERIX INC, $7.4, -79.20 pct

The drug developer said its oral antiviral drug for the treatment of a certain kind of infection in stem cell transplant patients did not meet the main goal in a late-stage study.

** ICONIX BRAND GROUP INC, $5.705, -23.42 pct

The owner of Umbro and Lee Cooper brands said it received an order of investigation from the Staff of the Securities and Exchange Commission related to the accounting for the formation of certain joint ventures.

** VALEANT PHARMACEUTICALS INTERNATIONAL INC, $104.23, -8.66 pct

The Canadian drugmaker said a group of company executives will take over in an interim capacity, until CEO Michael Pearson returns from medical leave.

** FITBIT INC, $29.75, +2.91 pct

The wearable fitness device maker scores No. 1 spot on Apple Inc's App Store chart for free apps on Dec. 25, according to media reports. This could indicate strong holiday demand for Fitbit's wearable gadgets.

** FREEPORT-MCMORAN INC, $7.04, -7.00 pct

The miner's co-founder, James Moffett, will step down as chairman and quit its board, months after the company added two directors under pressure from billionaire investor Carl Icahn.

** PSIVIDA CORP, $4.75, +8.70 pct

The drugmaker plans to file for European marketing approval of its rare disease drug, Medidur, for chronic non-infectious uveitis, an inflammation in the back of the eyes.

** TRANSOCEAN LTD, $12.68, -2.31 pct

Transocean, one of the world's largest offshore drilling companies, said on Monday that Shell had opted to terminate its contract for the harsh environment semisubmersible Polar Pioneer before the expiration in July 2017. (Reporting by Arunima Banerjee in Bengaluru; Editing by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below